FDA reminds health care facilities to use proper N95 sterilization processes
The Food and Drug Administration yesterday issued a reminder to health care facilities’ reprocessing staffs to follow the agency-outlined decontamination cycle when using the ASP STERRAD Sterilization System to decontaminate N95 or N95-equivalent respirators for reuse via vaporized hydrogen peroxide.
FDA April 11 authorized the device’s emergency use for the duration of the COVID-19 pandemic.
To ensure continued safe use of the device, the agency is repeating its sterilization process recommendations, which include material and cycle consideration, as well as agency-developed instructions and a fact sheet.
Related News Articles
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…